Stock N46 MEDICUS PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Medicus Pharma Ltd. Börse Stuttgart

Equities

N46

CA58471K1030

Market Closed - Börse Stuttgart
Other stock markets
 11:48:34 2024-07-09 am EDT 		5-day change 1st Jan Change
1.54 EUR +4.76% Intraday chart for Medicus Pharma Ltd. +31.25% 0.00%
Jul. 08 Medicus Pharma Ltd. announced that it has received $11.0175 million in funding CI
Jul. 05 Medicus Pharma up 7.4% as it Closes Private Placement, Conversion of Convertible Notes MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Medicus Pharma Ltd. announced that it has received $11.0175 million in funding
CI
Medicus Pharma up 7.4% as it Closes Private Placement, Conversion of Convertible Notes
MT
Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
NE
Medicus Pharma Ltd. announced that it has received $5.845 million in funding
CI
Medicus Pharma Ltd. Announces Proposed Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
NE
Medicus Pharma Ltd. announced that it expects to receive $5.845 million in funding
CI
Medicus Pharma Files Registration Statement for Proposed Initial Public Offering in the United States
MT
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
NE
Medicus Pharma Plans Private Placement for Clinical Development Acceleration
AQ
Medicus Pharma Ltd. Announces Closing of Private Placement of Convertible Notes
NE
Medicus Pharma Ltd. announced that it expects to receive $11.0175 million in funding
CI
Canadian Investment Regulatory Organization Trade Resumption - MDCX
AQ
Medicus Pharma Ltd. Announces Proposed Private Placement of Convertible Notes
NE
Canadian Investment Regulatory Organization Trading Halt - MDCX
AQ
Medicus Pharma Ltd. announced a financing transaction
CI
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003
AQ
Medicus Pharma Ltd. Announces the Receipt of Comments from the U.S Food and Drug Administration
CI
Medicus Pharma Ltd. Receives FDA Comments on Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin
NE
Medicus Pharma Names COO
MT
Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDCX Stock
  4. N46 Stock
  5. News Medicus Pharma Ltd.